BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Safory H, Neame S, Shulman Y, Zubedat S, Radzishevsky I, Rosenberg D, Sason H, Engelender S, Avital A, Hülsmann S, Schiller J, Wolosker H. The alanine-serine-cysteine-1 (Asc-1) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission. EMBO Rep 2015;16:590-8. [PMID: 25755256 DOI: 10.15252/embr.201439561] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Hamano M, Tomonaga S, Osaki Y, Oda H, Kato H, Furuya S. Transcriptional Activation of Chac1 and Other Atf4-Target Genes Induced by Extracellular l-Serine Depletion is negated with Glycine Consumption in Hepa1-6 Hepatocarcinoma Cells. Nutrients 2020;12:E3018. [PMID: 33023086 DOI: 10.3390/nu12103018] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wolosker H. The Neurobiology of d -Serine Signaling. Apprentices to Genius: A tribute to Solomon H. Snyder. Elsevier; 2018. pp. 325-48. [DOI: 10.1016/bs.apha.2017.08.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
3 Zafra F, Ibáñez I, Bartolomé-Martín D, Piniella D, Arribas-Blázquez M, Giménez C. Glycine Transporters and Its Coupling with NMDA Receptors. Adv Neurobiol 2017;16:55-83. [PMID: 28828606 DOI: 10.1007/978-3-319-55769-4_4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
4 Billard J, Freret T. Asc-1 transporter activation: an alternative to rescue age-related alterations in functional plasticity at rat hippocampal CA3/CA1 synapses. J Neurochem 2018;147:514-25. [DOI: 10.1111/jnc.14586] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Zafra F, Ibáñez I, Giménez C. Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies. Neuronal Signal 2017;1:NS20160009. [PMID: 32714574 DOI: 10.1042/NS20160009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
6 Sherwood MW, Oliet SHR, Panatier A. NMDARs, Coincidence Detectors of Astrocytic and Neuronal Activities. Int J Mol Sci 2021;22:7258. [PMID: 34298875 DOI: 10.3390/ijms22147258] [Reference Citation Analysis]
7 Wang Q, Zuo Z. Impact of transporters and enzymes from blood–cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake. Expert Opinion on Drug Metabolism & Toxicology 2018;14:961-72. [DOI: 10.1080/17425255.2018.1513493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
8 Sason H, Billard JM, Smith GP, Safory H, Neame S, Kaplan E, Rosenberg D, Zubedat S, Foltyn VN, Christoffersen CT, Bundgaard C, Thomsen C, Avital A, Christensen KV, Wolosker H. Asc-1 Transporter Regulation of Synaptic Activity via the Tonic Release of d-Serine in the Forebrain. Cereb Cortex 2017;27:1573-87. [PMID: 26796213 DOI: 10.1093/cercor/bhv350] [Cited by in Crossref: 19] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
9 Kurolap A, Armbruster A, Hershkovitz T, Hauf K, Mory A, Paperna T, Hannappel E, Tal G, Nijem Y, Sella E, Mahajnah M, Ilivitzki A, Hershkovitz D, Ekhilevitch N, Mandel H, Eulenburg V, Baris HN. Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. Am J Hum Genet 2016;99:1172-80. [PMID: 27773429 DOI: 10.1016/j.ajhg.2016.09.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
10 Armbruster A, Neumann E, Kötter V, Hermanns H, Werdehausen R, Eulenburg V. The GlyT1 Inhibitor Bitopertin Ameliorates Allodynia and Hyperalgesia in Animal Models of Neuropathic and Inflammatory Pain. Front Mol Neurosci 2017;10:438. [PMID: 29375301 DOI: 10.3389/fnmol.2017.00438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rodriguez CF, Escudero-Bravo P, Díaz L, Bartoccioni P, García-Martín C, Gilabert JG, Boskovic J, Guallar V, Errasti-Murugarren E, Llorca O, Palacín M. Structural basis for substrate specificity of heteromeric transporters of neutral amino acids. Proc Natl Acad Sci U S A 2021;118:e2113573118. [PMID: 34848541 DOI: 10.1073/pnas.2113573118] [Reference Citation Analysis]
12 Foster AC, Rangel-Diaz N, Staubli U, Yang JY, Penjwini M, Viswanath V, Li YX. Phenylglycine analogs are inhibitors of the neutral amino acid transporters ASCT1 and ASCT2 and enhance NMDA receptor-mediated LTP in rat visual cortex slices. Neuropharmacology 2017;126:70-83. [PMID: 28807674 DOI: 10.1016/j.neuropharm.2017.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kolodney G, Dumin E, Safory H, Rosenberg D, Mori H, Radzishevsky I, Wolosker H. Nuclear Compartmentalization of Serine Racemase Regulates D-Serine Production: IMPLICATIONS FOR N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ACTIVATION. J Biol Chem 2015;290:31037-50. [PMID: 26553873 DOI: 10.1074/jbc.M115.699496] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Suwandhi L, Altun I, Karlina R, Miok V, Wiedemann T, Fischer D, Walzthoeni T, Lindner C, Böttcher A, Heinzmann SS, Israel A, Khalil AEMM, Braun A, Pramme-Steinwachs I, Burtscher I, Schmitt-Kopplin P, Heinig M, Elsner M, Lickert H, Theis FJ, Ussar S. Asc-1 regulates white versus beige adipocyte fate in a subcutaneous stromal cell population. Nat Commun 2021;12:1588. [PMID: 33707431 DOI: 10.1038/s41467-021-21826-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Sakimura K, Nakao K, Yoshikawa M, Suzuki M, Kimura H. A novel Na(+) -Independent alanine-serine-cysteine transporter 1 inhibitor inhibits both influx and efflux of D-Serine. J Neurosci Res 2016;94:888-95. [PMID: 27302861 DOI: 10.1002/jnr.23772] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
16 Ehmsen JT, Liu Y, Wang Y, Paladugu N, Johnson AE, Rothstein JD, du Lac S, Mattson MP, Höke A. The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons. Sci Rep 2016;6:35592. [PMID: 27759100 DOI: 10.1038/srep35592] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
17 Neame S, Safory H, Radzishevsky I, Touitou A, Marchesani F, Marchetti M, Kellner S, Berlin S, Foltyn VN, Engelender S, Billard JM, Wolosker H. The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle. Proc Natl Acad Sci U S A 2019;116:20736-42. [PMID: 31548413 DOI: 10.1073/pnas.1909458116] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
18 Danaei N, Nooripour S. An Infant With Non-Ketotic Hyperglycemia: A Case Report. Middle East J Rehabil Health 2016;3. [DOI: 10.17795/mejrh-33423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Papouin T, Henneberger C, Rusakov DA, Oliet SH. Astroglial versus Neuronal D-Serine: Fact Checking. Trends in Neurosciences 2017;40:517-20. [DOI: 10.1016/j.tins.2017.05.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 10.4] [Reference Citation Analysis]
20 Brill SE, Maraslioglu A, Kurz C, Kramer F, Fuhr MF, Singh A, Friauf E. Glycinergic Transmission in the Presence and Absence of Functional GlyT2: Lessons From the Auditory Brainstem. Front Synaptic Neurosci 2020;12:560008. [PMID: 33633558 DOI: 10.3389/fnsyn.2020.560008] [Reference Citation Analysis]
21 Mesuret G, Khabbazzadeh S, Bischoff AM, Safory H, Wolosker H, Hülsmann S. A neuronal role of the Alanine-Serine-Cysteine-1 transporter (SLC7A10, Asc-1) for glycine inhibitory transmission and respiratory pattern. Sci Rep 2018;8:8536. [PMID: 29867218 DOI: 10.1038/s41598-018-26868-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Zhan FX, Wang SG, Cao L. Advances in hyperekplexia and other startle syndromes. Neurol Sci 2021;42:4095-107. [PMID: 34379238 DOI: 10.1007/s10072-021-05493-8] [Reference Citation Analysis]
23 Tapanes SA, Arizanovska D, Díaz MM, Folorunso OO, Harvey T, Brown SE, Radzishevsky I, Close LN, Jagid JR, Graciolli Cordeiro J, Wolosker H, Balu DT, Liebl DJ. Inhibition of glial D-serine release rescues synaptic damage after brain injury. Glia 2022. [PMID: 35195906 DOI: 10.1002/glia.24161] [Reference Citation Analysis]
24 Kono Y, Hülsmann S. Presynaptic facilitation of glycinergic mIPSC is reduced in mice lacking α3 glycine receptor subunits. Neuroscience 2016;320:1-7. [PMID: 26851771 DOI: 10.1016/j.neuroscience.2016.01.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Yin J, Sun W, Li F, Hong J, Li X, Zhou Y, Lu Y, Liu M, Zhang X, Chen N, Jin X, Xue J, Zeng S, Yu L, Zhu F. VARIDT 1.0: variability of drug transporter database. Nucleic Acids Res 2020;48:D1042-50. [PMID: 31495872 DOI: 10.1093/nar/gkz779] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
26 Torrecillas IR, Conde-Ceide S, de Lucas AI, Garcı A Molina A, Trabanco AA, Lavreysen H, Pardo L, Tresadern G. Inhibition of the Alanine-Serine-Cysteine-1 Transporter by BMS-466442. ACS Chem Neurosci 2019;10:2510-7. [PMID: 30821959 DOI: 10.1021/acschemneuro.9b00019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
27 Suzuki M, Gonda Y, Yamada M, Vandebroek AA, Mita M, Hamase K, Yasui M, Sasabe J. Serum D-serine accumulation after proximal renal tubular damage involves neutral amino acid transporter Asc-1. Sci Rep 2019;9:16705. [PMID: 31723194 DOI: 10.1038/s41598-019-53302-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wolosker H, Balu DT. D-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders. Transl Psychiatry 2020;10:184. [PMID: 32518273 DOI: 10.1038/s41398-020-00870-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 Errasti-Murugarren E, Palacín M. Heteromeric Amino Acid Transporters in Brain: from Physiology to Pathology. Neurochem Res 2021. [PMID: 33606172 DOI: 10.1007/s11064-021-03261-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tatsumi K, Kinugawa K, Isonishi A, Kitabatake M, Okuda H, Takemura S, Tanaka T, Mori E, Wanaka A. Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain. Mol Brain 2021;14:163. [PMID: 34749773 DOI: 10.1186/s13041-021-00874-8] [Reference Citation Analysis]
31 Mothet J, Le Bail M, Billard J. Time and space profiling of NMDA receptor co-agonist functions. J Neurochem 2015;135:210-25. [DOI: 10.1111/jnc.13204] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 8.6] [Reference Citation Analysis]